Top 5 Prescription NSAIDs for Dogs in Canada 2026: Meloxicam, Carprofen, Deracoxib, Firocoxib, Robenacoxib - A Veterinarian-Recommended, Evidence-Based Guide
Published on Wednesday, February 25, 2026
Veterinary nonsteroidal anti-inflammatory medications (NSAIDs) are prescription drugs used to control pain, fever, and systemic inflammation in dogs. Commonly prescribed for osteoarthritis, postoperative pain, and injury, these agents help improve mobility and quality of life when used under veterinary supervision. Canadian pet owners often choose an NSAID based on demonstrated efficacy, dosing convenience, formulation options (tablet, chewable, or injectable), safety profile for their dog, cost and availability, and recommendations from their veterinarian. Because NSAIDs can affect the gastrointestinal tract, kidneys, and liver, reliable monitoring, individualized dosing, and clear communication with a licensed Canadian veterinarian are essential to minimize risks and achieve the best outcomes.
Top Picks Summary
Rimadyl Chewable Tablets
Rimadyl (carprofen) chewables are a market leader because of their long clinical track record for osteoarthritis and postoperative pain, broad veterinary acceptance, and wide availability of branded and generic formulations that can lower out‑of‑pocket cost. Rimadyl’s palatable chewable format improves owner compliance compared with liquids, and its established efficacy profile makes it a common first‑line NSAID compared with newer agents that emphasize safety or different mechanisms.
Show More Prescription Nonsteroidal Anti-Inflammatory Oral Tablets and Chewables for Dogs
Metacam Oral Suspension 1.5mg/mL
Metacam is positioned as the market-leading, reference-brand meloxicam oral suspension due to its long record of veterinary clinical use and regulatory approvals; clinics favor it for consistent manufacturing standards and comprehensive pharmacovigilance. While typically priced higher than generics on this list, Metacam’s brand recognition and proven label dosing make it the preferred choice for practices that prioritize predictable supply and documented clinical data over lower-cost alternatives.
Show More Prescription Nonsteroidal Anti-Inflammatory Oral Liquid Suspensions for Dogs
Metacam 5 mg/mL Solution for Injection
Metacam (meloxicam) holds a best-in-class position because of its long track record in dogs, predictable pharmacology and a well-established safety profile for perioperative and short-term postoperative pain control, making it a financially sensible choice for clinics that value reliability. Compared with the other injectables on this list it offers broad clinical familiarity and typically lower monitoring burden than older nonselective options like ketoprofen (Anafen), though it is less COX-2 selective than firocoxib (Previcox) and robenacoxib (Onsior). Its combination of efficacy, availability and often-competitive pricing versus branded COX-2 agents helps explain its widespread veterinary use for prescription injectable NSAID therapy in dogs.
Show More Prescription Nonsteroidal Anti-Inflammatory Injectables for Dogs
Previcox Chewable Tablets
Previcox (firocoxib) is a COX-2–selective oral NSAID that is often positioned for once-daily convenience and a safety profile that many clinicians prefer for chronic management, making it a market leader among COX-2 selective chewables. For the topical-use focused list, Previcox represents the systemic, longer-acting alternative that can reduce dosing frequency and improve adherence compared with multiple daily topical applications, though it usually carries higher per-tablet pricing than some generic options. Its technical advantage is selectivity for inflammatory pathways, which can be a differentiator when comparing adverse-event monitoring and downstream healthcare costs to nonselective NSAIDs.
Show More Prescription Nonsteroidal Anti-Inflammatory Topical Gels and Sprays for Dogs
Previcox firocoxib
Previcox (firocoxib) is a highly COX-2 selective NSAID commonly used for once-daily management of canine osteoarthritis, known for its predictable dosing and favorable long-term safety profile. As a market leader for COX-2–specific therapy, Previcox competes by offering reliable efficacy combined with strong value where generics are available, often undercutting the cost of some branded short-term or perioperative options while maintaining a focused COX-2 benefit.
Show More Prescription Nonsteroidal Anti-Inflammatory Products by Active Ingredient for Dogs
What the Research Says: Safety and Effectiveness of Canine NSAIDs
Clinical trials and systematic reviews support the use of NSAIDs for reducing pain and improving function in dogs with osteoarthritis and for controlling postoperative pain when administered appropriately. Evidence highlights that efficacy, onset of action, and side effect profiles differ across drugs and formulations. Best-practice guidelines recommend baseline bloodwork, individualized dosing, and periodic monitoring to detect renal, hepatic, or gastrointestinal adverse effects early. Veterinary regulators in Canada require prescriptions and emphasize practitioner oversight to ensure safe use.
Efficacy: Randomized controlled trials show meaningful reductions in pain and lameness scores for dogs with osteoarthritis when treated with approved canine NSAIDs compared with placebo.
Postoperative analgesia: Studies support short-term NSAID use to decrease acute postoperative pain and improve recovery after soft tissue and orthopedic procedures.
Safety profile: COX-2 selective agents may reduce gastrointestinal side effects in some patients, but selectivity is not a guarantee of safety; individual factors matter.
Monitoring recommendations: Veterinary guidance and retrospective studies recommend baseline hematology and biochemistry, with follow-up testing during long-term use or if clinical signs arise.
Risk factors: Older dogs, dehydrated patients, or dogs with preexisting renal or hepatic disease have higher risk for adverse events; concomitant use of corticosteroids or multiple NSAIDs is contraindicated.
Regulatory context: Health Canada and veterinary authorities require prescription status and professional oversight; approved drugs have species-specific dosing and label instructions.
Frequently Asked Questions
Which prescription NSAID should my dog start with?
For most dogs needing controlled pain and inflammation, Metacam Oral Suspension 1.5mg/mL is a strong pick because it’s brand-name meloxicam (1.5 mg/mL) for canine use, prescription-only, and rated 4.4.
Does Previcox chewable offer COX-2 selectivity and dosing?
Previcox Chewable Tablets are designed as COX-2 selective for inflammation control, with once-daily flavored chewable tablets for chronic osteoarthritis dosing; it’s prescription-only and rated 4.4.
What do I get for the price with Metacam?
I can’t compare prices because no Canadian pricing is provided in the product data; Metacam Oral Suspension 1.5mg/mL is listed at a 4.4 rating and comes as a 4.4 mg/mL prescription-only liquid for precise, weight-based dosing.
Are these NSAIDs for dogs compatible with other NSAIDs?
Previcox Chewable Tablets require caution when combining with other NSAIDs, and you should monitor liver enzymes; it’s prescription-only and rated 4.4.
Conclusion
In the Canadian context, prescription NSAIDs remain a cornerstone of canine pain management when prescribed and monitored by a veterinarian. We hope this overview helped you understand why Meloxicam, Carprofen, Deracoxib, Firocoxib, and Robenacoxib are frequently recommended options in 2026. If you did not find exactly what you needed, refine or broaden your search above, or consult your veterinarian for a personalized plan tailored to your dog.